A number of late-phase clinical trials in lymphoma and multiple myeloma (MM) have opened in…
View More New Trials in Lymphoma and MM: Could Your Patient Benefit?
Home »
Immunomodulatory drugs improve the success rate of cancer therapies
Immunomodulatory drugs, including the Contergan derivatives lenalidomide and pomalidomide, have significantly improved the therapy of…
View More Immunomodulatory drugs improve the success rate of cancer therapies
Kyprolis
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KYPROLIS® Carfilzomib…
View More Kyprolis
Multiple myeloma: DNA rearrangement may predict poor outcomes
A certain type of DNA marker predicts poor outcomes in multiple myeloma, researchers at Winship…
View More Multiple myeloma: DNA rearrangement may predict poor outcomes